RESUMO
In recent years, many studies on photocatalysis focused on improving efficiency. However, the cycle performance is also an important index for industrialization. Here, an Ag2O/TiO2 heterostructure photocatalyst is prepared for continuous photodegradation of methylene blue (MB) under visible light, and the samples after the first and fifth round reactions are recycled to study the microstructure evolution of the photocatalyst. The results show that the performance is obviously improved in the second round and remains stable in the following reaction round. Due to the charge transfer, Ag2O/TiO2 gradually changes to Ag2O@Ag-TiO2-x during the photocatalytic reaction. The resulting localized surface plasmon resonance effect and the change of the interface structure greatly increase the number of carriers and prolong the lifetime of carriers. Such variations of microstructures and photoelectric properties of the samples due to the charge transfer and redox reaction on the surface of the photocatalyst dominate the cycle performance.
RESUMO
The electrode-electrolyte contact issue within the composite electrode layer is a grand challenge for all-solid-state Li batteries. In order to achieve cycling performances comparable to Li-ion batteries based on liquid electrolyte, the aforementioned solid-solid contact not only needs to be sufficiently thorough but also must tolerate repeated cycling. Simultaneously meeting both requirements is rather challenging. Here, we discover that epitaxy may effectively overcome such bottlenecks even when the electrode undergoes repeated phase transitions during cycling. Through epitaxial growth, the perovskite Li0.33La0.56TiO3 solid electrolyte was found capable of forming atomically intimate contact with both the spinel Li4Ti5O12 and rock-salt Li7Ti5O12. In contrast to conventional expectations, such epitaxial interfaces can also survive repeated spinel-to-rock-salt phase transitions. Consequently, the Li4Ti5O12-Li0.33La0.56TiO3 composite electrode based on epitaxial solid-solid contact delivers not only a rate capability comparable to that of the surry-cast one with solid-liquid contact but also an excellent long-term cycling stability.
RESUMO
Elemental doping and surface modification are commonly used strategies for improving the electrochemical performance of LiMn2O4, such as the rated capacity and cycling stability. In this study, in situ formed core-shell LiZnxMn2-xO4@ZnMn2O4 cathodes are prepared by tuning the Zn-doping content. Through comprehensive microstructural analyses by the spherical aberration-corrected scanning transmission microscopy (Cs-STEM) technique, we shed light on the correlation between the microstructural configuration and the electrochemical performance of Zn-doped LiMn2O4. We demonstrate that part of Zn2+ ions dope into the spinel to form LiZnxMn2-xO4 in bulk and other Zn2+ ions occupy the 8a sites of the spinel to form the ZnMn2O4 shell on the outermost surface. This in situ formed core-shell LiZnxMn2-xO4@ZnMn2O4 contributes to better structural stabilization, presenting a superior capacity retention ratio of 95.8% after 700 cycles at 5 C at 25 °C for the optimized sample (LiZn0.02Mn1.98O4), with an initial value of 80 mAh g-1. Our investigations not only provide an effective way toward high-performance LIBs but also shed light on the fundamental interplay between the microstructural configuration and the electrochemical performance of Zn-doped spinel LiMn2O4.
RESUMO
Nanoscale tellurium (Te) materials are promising for advanced optoelectronics owing to their outstanding photoelectrical properties. In this work, high-performance optoelectronic nanodevice based on a single tellurium nanotube (NT) was prepared by focused ion beam (FIB)-assisted technique. The individual Te NT photodetector demonstrates a high photoresponsivity of 1.65 × 104 AW-1 and a high photoconductivity gain of 5.0 × 106%, which shows great promise for further optoelectronic device applications.
RESUMO
It is well known that the electrochemical performance of spinel LiMn2O4 can be improved by Al doping. Herein, combining X-ray diffraction, Raman spectroscopy, X-ray photoelectron spectroscopy, and spherical aberration-corrected scanning transmission electron microscopy (Cs-STEM) with in situ electron-beam (E-beam) irradiation techniques, the influence of Al doping on the structural evolution and stability improvement of the LiMn2O4 cathode material is revealed. It is revealed that an appropriate concentration of Al3+ ions could dope into the spinel structure to form a more stable LiAlxMn2-xO4 phase framework, which can effectively stabilize the surface and bulk structure by inhibiting the dissolution of Mn ions during cycling. The optimized LiAl0.05Mn1.95O4 sample exhibits a superior capacity retention ratio of 80% after 1000 cycles at 10 C (1 C = 148 mA h g-1) in the voltage range of 3.0-4.5 V, which possesses an initial discharge capacity of 90.3 mA h g-1. Compared with the undoped LiMn2O4 sample, the Al-doped sample also shows superior rate performance, especially the capacity recovery performance.
RESUMO
Ti-doped truncated octahedron LiTixMn2-xO4 nanocomposites were synthesized through a facile hydrothermal treatment and calcination process. By using spherical aberration-corrected scanning transmission electron microscopy (Cs-STEM), the effects of Ti-doping on the structure evolution and stability enhancement of LiMn2O4 are revealed. It is found that truncated octahedrons are easily formed in Ti doping LiMn2O4 material. Structural characterizations reveal that most of the Ti4+ ions are composed into the spinel to form a more stable spinel LiTixMn2-xO4 phase framework in bulk. However, a portion of Ti4+ ions occupy 8a sites around the {001} plane surface to form a new TiMn2O4-like structure. The combination of LiTixMn2-xO4 frameworks in bulk and the TiMn2O4-like structure at the surface may enhance the stability of the spinel LiMn2O4. Our findings demonstrate the critical role of Ti doping in the surface chemical and structural evolution of LiMn2O4 and may guide the design principle for viable electrode materials.
RESUMO
A novel electrocatalytic material VS2@V2C was proposed for the first time and successfully prepared by a one-step hydrothermal method. T-VS2 nanosheets were uniformly and vertically embedded on the V2C (MXene) matrix with a fewer layer structure. Owing to the fast charge transfer process at the interface of the two-phase structure and good conductivity, the composite material showed a lower hydrogen evolution overpotential and a very low Tafel slope in highly alkaline and highly acidic electrolytes (164 mV and 47.6 mV dec-1 in 1.0 M KOH; 138 mV and 37.9 mV dec-1 in 0.5 M H2SO4) under a current density of 20 mV cm-2. More importantly, high-efficiency and stable electrolysis of seawater was achieved at a current density greater than 100 mA cm-2, and the catalytic performance was significantly better than that of platinum-based alloys. First-principles calculations mechanically confirmed that VS2@V2C had higher carrier mobility and lower free energy of hydrogen adsorption. The VS2 nanosheets that grew outwards could provide support to avoid agglomeration on the catalyst surface and the edge sulfur sites of VS2 could promote the binding of adsorbed hydrogen atoms and the desorption of hydrogen molecules. Our work is expected to provide a valuable reference for the design and synthesis of the structure of industrial catalysts for hydrogen production from seawater in the future.
RESUMO
OBJECTIVE: To study the expression of WAVE1 and p22phox in peripheral blood mononuclear cells (PBMCs) in children with acute lymphocytic leukemia (ALL) and the relationship of WAVE1 with oxidative stress. METHODS: Real-time PCR was used for detecting WAVE1 and p22phox expression in PBMCs in 41 children with ALL and 10 normal controls. Plasma activity of superoxide dismutase (SOD) was measured by the xanthine oxidase method. Plasma activity of GSH-Px was measured by the DTNB reaction test. RESULTS: The expression of WAVE1 and p22phox was significantly higher in the active ALL groups (newly diagnosed and relapse ALL) than that in the normal control and the complete remission (CR) ALL groups (<0.01). The CR ALL group showed increased WAVE1 and p22phox expression than those in the normal control group (<0.05). Plasma activities of SOD (22.62+/-7.39 U/mL) and GSH-Px (91.73+/-28.88 micromol/L) in the active ALL group were significantly lower than those in the normal control (166.35+/-27.93 U/mL and 490.94+/-39.38 micromol/L, respectively) and the CR ALL groups (107.11+/-28.57 U/mL and 267.56+/-82.64 micromol/L, respectively) (<0.01). WAVE1 expression was positively correlated with p22phox expression (r=0.34, <0.05) but negatively correlated with plasma activities of SOD and GSH-Px ( r=-0.336 and-0.408, respectively; <0.05). CONCLUSIONS: WAVE1 and p22phox expression in PBMCs increased and was associated with the disease course in children with ALL. Oxidative stress may be involved in the regulation of WAVE1 expression in ALL children.
Assuntos
Leucócitos Mononucleares/metabolismo , NADPH Oxidases/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/metabolismo , Família de Proteínas da Síndrome de Wiskott-Aldrich/genética , Adolescente , Criança , Pré-Escolar , Feminino , Glutationa Peroxidase/sangue , Humanos , Lactente , Masculino , Estresse Oxidativo , Reação em Cadeia da Polimerase , RNA Mensageiro/sangue , Superóxido Dismutase/sangueRESUMO
OBJECTIVE: To investigate whether WASP/Verprolin homologous protein 1 (WAVE1) plays a role in the pathogenesis of childhood acute lymphoblastic leukemia (ALL). METHODS: WAVE1 mRNA and protein expression in bone marrow mononuclear cells (BMMCs) was measured by RT-PCR and Western blotting respectively in 4 children with ALL relapse, 15 children with ALL in complete remission (CR) and 40 children with newly diagnosed ALL. Ten normal bone marrow samples were used as controls. Jurkat cells were treated with different concentrations of adriamycin (ADM). The cell proliferation was detected with MTT. The apoptosis rate was measured by flow cytometry. WAVE1 mRNA and protein expression of Jurkat cells treated with ADM was detected by RT-PCR and Western blotting respectively. RESULTS: WAVE1 was not expressed or weakly expressed in BMMCs from normal controls and patients with ALL in CR. Higher WAVE1 mRNA and protein expression was found in BMMCs from patients with newly diagnosed ALL and patients with relapse ALL when compared with the controls and the patients in CR (P<0.01). ADM significantly inhibited the proliferation of the Jurkat cells and the inhibitory effect was dose-and time-dependent (P<0.05). After ADM treatment for 24 hrs, the percentage of apoptosis cells increased significantly and WAVE1 mRNA and protein expression of Jurkat cells decreased significantly when compared with the untreated controls (P<0.05). CONCLUSIONS: The WAVE1 expression increased in children with ALL. WAVE1 may be related to the development of ALL and may be severed as a marker for the evaluation of the severity of ALL in children.
Assuntos
Antibióticos Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Doxorrubicina/farmacologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/metabolismo , Família de Proteínas da Síndrome de Wiskott-Aldrich/fisiologia , Adolescente , Western Blotting , Proliferação de Células/efeitos dos fármacos , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Células Jurkat , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/etiologia , RNA Mensageiro/análise , Família de Proteínas da Síndrome de Wiskott-Aldrich/análise , Família de Proteínas da Síndrome de Wiskott-Aldrich/genéticaRESUMO
Controllable mechanical strength and biodegradation of bioceramic scaffolds is a great challenge to treat the load-bearing bone defects. Herein a new strategy has been developed to fabricate porous bioceramic scaffolds with adjustable component distributions based on varying the core-shell-structured nozzles in three-dimensional (3D) direct ink writing platform. The porous bioceramic scaffolds composed of different nonstoichiometic calcium silicate (nCSi) with 0%, 4% or 10% of magnesium-substituting-calcium ratio (CSi, CSi-Mg4, CSi-Mg10) was fabricated. Beyond the mechanically mixed composite scaffolds, varying the different nCSi slurries through the coaxially aligned bilayer nozzle makes it easy to create core-shell bilayer bioceramic filaments and better control of the different nCSi distribution in pore strut after sintering. It was evident that the magnesium substitution in CSi contributed to the increase of compressive strength for the single-phasic scaffolds from 11.2â¯MPa (CSi), to 39.4â¯MPa (CSi-Mg4) and 80â¯MPa (CSi-Mg10). The nCSi distribution in pore struts in the series of core-shell-strut scaffolds could significantly adjust the strength [e.g. CSi@CSi-Mg10 (58.9â¯MPa) vs CSi-Mg10@CSi (30.4â¯MPa)] and biodegradation ratio in Tris buffer for a long time stage (6 weeks). These findings demonstrate that the nCSi components with different distributions in core or shell layer of pore struts lead to tunable strength and biodegradation inside their interconnected macropore architectures of the scaffolds. It is possibly helpful to develop new bioactive scaffolds for time-dependent tailoring mechanical and biological performances to significantly enhance bone regeneration and repair applications, especially in some load-bearing bone defects.
Assuntos
Materiais Biocompatíveis/química , Compostos de Cálcio/química , Cerâmica/química , Fenômenos Mecânicos , Silicatos/química , Tinta , Teste de Materiais , Porosidade , Impressão TridimensionalRESUMO
OBJECTIVE: To investigate role of WASP family verprolin homologous protein 1 (WAVE1) in K562 leukemia cell invasion and its mechanism. METHODS: Immunofluorescence method was used to detect the distribution of WAVE1 and MMP-2 in the cells. K562 cells were transfected with pcDNA3. 1-WAVE1 reconstructed plasmid or with specific siRNA to WAVE1 gene. The invasion ability of K562 cells was examined by Transwell assay. The expression level of WAVE1 and MMP-2 in K562 cells was assayed by real-time PCR and Western blot. RESULTS: (1) WAVE1 and MMP-2 mainly expressed and co-localized in the cell membrane; (2) 24 h and 48 h after transfected with pcDNA3. 1-WAVE1, the MMP-2 mRNA level in K562 cells increased by 295% and 198% while its protein increased by 80% and 23% respectively as compared with control K562 cells. At the same time point after transfected with specific siRNA, the MMP-2 mRNA level decreased by 81% and 28%, and its protein decreased by 36% and 53% respectively as compared with control. (3) The invasion ability of K562 cells was enhanced after transfected with pcDNA3. 1-WAVE1 and depressed after transfected with the specific siRNA. CONCLUSION: The co-localization of WAVE1 and MMP-2 in K562 cells suggests they coordinate in functions; WAVE1 may involve in the migration and invasion of K562 cells through regulating the expression level of MMP-2.
Assuntos
Infiltração Leucêmica/fisiopatologia , Família de Proteínas da Síndrome de Wiskott-Aldrich/metabolismo , Humanos , Células K562 , Infiltração Leucêmica/genética , Infiltração Leucêmica/metabolismo , Metaloproteinase 2 da Matriz/genética , Metaloproteinase 2 da Matriz/metabolismo , RNA Mensageiro/genética , RNA Interferente Pequeno/genética , Transfecção , Família de Proteínas da Síndrome de Wiskott-Aldrich/genéticaRESUMO
BACKGROUND & OBJECTIVE: High mobility group box l (HMGB1), a nuclear DNA-binding protein, stabilizes the structure and function of chromatin, regulates gene transcription. Recent studies found that HMGB1 is associated with the proliferation and metastasis of many tumors, including breast cancer, colon carcinoma, and melanoma, and is rich in various solid cancer tissues and immature cells. This study was to explore the role of HMGB1 in adriamycin (ADM)-induced apoptosis in leukemia K562 cells. METHODS: K562 cells were transiently transfected with recombinant plasmid pcDNA3.1-HMGB1. The expression of HMGB1 in K562 cells were detected by Western blot and reverse transcription-polymerase chain reaction (RT-PCR). The 50% inhibition concentration (IC(50)) of ADM for K562 cells was determined by WST-8 assay. Cell apoptosis was assessed by flow cytometry. The protein level of Bcl-2 was detected by Western blot. The activities of Caspase-3 and Caspase-9 were assayed with Caspase Colorimetric Assay Kit. RESULTS: The mRNA and protein levels of HMGB1 in K562 cells transfected with pcDNA3.1-HMGB1 were increased by about 85% and 56% respectively as compared with those in K562 cells transfected with pcDNA3.1. Overexpression of HMGB1 in K562 cells by transient transfection significantly increased the resistance to ADM; the IC(50) of ADM was increased from (0.06+/-0.00) microg/mL to (3.46+/-0.06) microg/mL. When treated with 1 microg/mL ADM, the apoptosis rate was significantly lower in HMGB1-transfected K562 cells than in pcDNA3.1-transfected K562 cells [(12.00+/-1.26)% vs. (44.50+/-1.87)%, P<0.05]. Overexpression of HMGB1 in K562 cells significantly inhibited ADM-induced down-regulation of Bcl-2 protein. After treatment of ADM, the activities of Caspase-3 and Caspase-9 in HMGB1-transfected K562 cells were inhibited as compared with those in pcDNA3.1-transfected K562 cells (Caspase-3: 1.55+/-0.06 vs. 2.55+/-0.06 at 12 h, 1.86+/-0.10 vs. 2.85+/-0.06 at 24 h, P<0.05; Caspase-9: 1.40+/-0.08 vs. 2.03+/-0.05 at 12 h, 1.55+/-0.06 vs. 2.22+/-0.05 at 24 h, P<0.05). CONCLUSION: HMGB1 overexpression could inhibit ADM-induced apoptosis in leukemia K562 cells through regulating the protein level of Bcl-2 and the activities of Caspase-3 and Caspase-9.
Assuntos
Apoptose , Caspase 3/metabolismo , Caspase 9/metabolismo , Doxorrubicina/farmacologia , Proteína HMGB1/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Antibióticos Antineoplásicos/farmacologia , Regulação para Baixo , Resistencia a Medicamentos Antineoplásicos , Proteína HMGB1/metabolismo , Humanos , Células K562 , Plasmídeos , RNA Mensageiro/metabolismo , TransfecçãoRESUMO
OBJECTIVE: To investigate the effect of high mobility group boxl (HMGBI) gene silence on adriamycin (ADM)-induced apoptosis in K562/A02 drug resistance leukemia cells. METHODS: K562/ A02 cells were transient transfected with HMGB1- small interference RNA(siRNA) vector, and the levels of HMGB1 gene differential expression pre-and post-transfection were measured by RT-PCR and Western blotting. 50% inhibition concentration (IC50) of ADM on K562/A02 was determined by WST-8 assay. Cell apoptosis was assessed by flow cytometry. The release of Smac/DIABLO from the mitochondria to the cytoplasm was assayed by Western blotting. Activity of Caspase-3 was assayed with a Caspase Colorimetric Assay Kit. RESULTS: (1) The HMGB1 expression at mRNA and protein levels in HMGB1 siRNA transfected K562/A02 cells were decreased by 86% and 71% respectively compared with control. (2) Suppression of HMGB1 by siRNA in K562/A02 cells resulted in a reversal of the resistance to ADM, and decreased IC50 from (4.83 +/- 0.08) microg/ml to (1.33 +/- 0.10) microg/ml. 1 microg/ml and 5 microg/ml of ADM treatment increased cell apoptotic rate by 27% and 32% respectively. (3) HMGB1 suppression in K562/A02 cells significantly promoted ADM- induced Smac/DIABLO release from the mitochondria to the cytoplasm, and increased the activities of Caspase-3. CONCLUSION: HMGB1 gene silence can enhance sensitivity of K562/A02 cells to ADM and reverse cell resistant to ADM.
Assuntos
Doxorrubicina/farmacologia , Inativação Gênica , Proteína HMGB1/genética , RNA Interferente Pequeno/genética , Apoptose/efeitos dos fármacos , Apoptose/genética , Humanos , Células K562RESUMO
OBJECTIVE: To analyze the therapeutic effect and the influencing factors of event-free survival (EFS) of childhood acute lymphoblastic leukemia (ALL) in Xiangya Hospital of Central South University and the First Affiliated Hospital of Guangxi Medical University. METHODS: All the patients adopted chemotherapy according to therapeutic guideline revised by the Subspecialty Group of Hematology, The Society of Pediatrics, Chinese Medical Association for the second-time in 1998 (the Rongcheng ALL-98 Protocol). Kaplan-Meier method was used to estimate the survival rates of 188 patients who received therapy with good compliance. The differences of EFS between groups were assessed by Log-rank test. The independent influencing factors on EFS were analyzed by the Cox proportional hazards regression model. RESULTS: After receiving inductive treatment, 354 of 374 (93.6%) patients demonstrated a complete remission; 188 patients who received complete courses of treatment with good compliance showed (68.1 +/- 5.6)% five-year EFS. Meanwhile, the five-year EFS in standard-risk (SR) group and high-risk (HR) group were (75.2 +/- 6.0)% and (47.6 +/- 11.6)%, respectively. The total relapse rate was 10.6% and the median time to relapse was 13 months. Twenty-nine of 188 patients (15.4%) were dead, and 13 patients (7.0%) died from treatment-related complications. Independent adverse prognostic factors included risk grouping, t (9; 22)/bcr-abl gene and leukocyte count. CONCLUSIONS: The total EFS of childhood ALL patients treated with Rongcheng ALL-98 Protocol in two hospitals was close to 70%. Therefore, it is necessary to evaluate risk factors and consider the grouping in more detail to reduce the treatment-related mortality and to increase the compliance of treatment which can ultimately improve the EFS.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Adolescente , Criança , Pré-Escolar , China/epidemiologia , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/epidemiologia , Prognóstico , Taxa de Sobrevida , Resultado do TratamentoRESUMO
OBJECTIVE: To investigate if WAVE1 is involved in mult drug-resistance (MDR) of human leukemia cell line K562/A02. METHODS: The level of WAVE1 in K562 and K562/A02 cells was assayed by Western blot and RT-PCR; K562 cells and K562/A02 cells were transient transfected with pEFBOS-WAVE1 reconstructed plasmid or specifically siRNA to WAVE1. 50% inhibition concentration (IC50) of doxorubicin on K562/A02 was determined by WST-8 assay. Hoechst33258 staining was used to examine cell morphological changes and to calculate percentage of apoptotic nuclei. The mRNA level of mdrl was assayed by RT-PCR. The Bcl-2 protein was assayed by Western blot. RESULTS: 1. The WAVE1 expression at mRNA and protein level in K562/A02 cells was increased by about 70% and 63% respectively as compared with that in K562 cells. 2. Overexpression of WAVE1 in K562 cells by transient transfection significantly increased the resistance to doxorubicin, and increased IC50 from (0.05 +/- 0.00) microg/ml to (2.99 +/- 0.12) microg/ml, and at 1 microg/ml or 5 microg/ml of doxorubicin treatment, cell apoptotic nuclei rate was decreased by 30% or 35% respectively. 3. Suppression of WAVE1 in K562/A02 cells by siRNA resulted in a reversal of MDR to doxorubicin, and decreased IC50 from (4.29 +/- 0.15) microg/ml to (1.85 +/- 0.07) microg/ml, and at 1 microg/ml or 5 microg/ml of doxorubicin treatment, cell apoptotic nuclei rate was increased by 24% or 21% respectively. 4. Overexpression of WAVE1 in K562 cells significantly increased the mdrl mRNA and the Bcl-2 protein, and suppression of WAVE1 in K562/A02 cells by siRNA decreased the mRNA and the protein. CONCLUSION: WAVE1 involves in the MDR mechanisms in K562/A02 leukemia cells through regulation the level of mdrl and Bcl-2.